title: Are drug-eluting stents safe?: Definitely! Or probably... possibly? Or maybe not yet....
authors.affiliation: CV Path Institute, Gaithersburg, Maryland, USA.
authors.forename: G
authors.initials: G
authors.lastname: Nakazawa
authors.forename: E
authors.initials: E
authors.lastname: Ladich
authors.forename: R
authors.initials: R
authors.lastname: Virmani
mesh_terms: D000497:Alloys; D002317:Cardiovascular Agents / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D023903:Coronary Restenosis / Q000517:prevention & control*; D054855:Drug-Eluting Stents / Q000009:adverse effects*; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology*; D015994:Incidence; D017239:Paclitaxel / Q000009:adverse effects; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012307:Risk Factors; D020123:Sirolimus / Q000009:adverse effects; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control; D013997:Time Factors
chemical_list: D000497:Alloys; D002317:Cardiovascular Agents; D010975:Platelet Aggregation Inhibitors; D017239:Paclitaxel; D020123:Sirolimus